University of Southern California
Tariq Warsi is an accomplished professional in the biotechnology sector, currently serving as the Investment Director at the Alfred E. Mann Institute, University of Southern California, and as an Entrepreneur in Residence at the University of California, Riverside. With a PhD in Cell and Molecular Biology from the University of California, Riverside, Tariq possesses extensive experience in technical operations, process development, and regulatory compliance, particularly in cell and gene therapies. Key roles include Senior Director at Neogene Therapeutics, where responsibilities encompassed overseeing process development for various cell therapy modalities and successfully managing cross-site teams, as well as Vice President of Technical Operations at Novome Biotechnologies, where Tariq led teams in delivering clinical drug products. Past experiences also involve leadership positions at Capricor Therapeutics, Syntheseas Inc., Amgen, OS Fund, and Stanford University, providing expert insights into scientific due diligence and innovative research strategies.
This person is not in any teams
University of Southern California
99 followers
The University of Southern California is a leading private research university located in Los Angeles, the capital of the Pacific Rim. This is the official LinkedIn presence for the University of Southern California. This account is managed and mediated by the staff of USC University Communications. Content (including posts from 3rd parties) that include videos, photographs, opinions and links to content outside of this channel do not necessarily represent the University of Southern California’s academic goals or opinions. Community guidelines: Alumni and students are welcome to post professional updates and news. Posts containing solicitations, product placements, derogatory or inflammatory comments are prohibited and will be removed. Off-topic comments will also be removed.